相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
Daniel J. Wallace et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
B cells: depletion or functional modulation in rheumatic diseases
Thomas Doerner et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
C-4 Modified Sialosides Enhance Binding to Siglec-2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy
Sorge Kelm et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
CD22 ligation inhibits downstream B cell receptor signaling and Ca2+flux upon activation
N. Sieger et al.
ARTHRITIS AND RHEUMATISM (2013)
Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab
Edmund A. Rossi et al.
BLOOD (2013)
Genetic susceptibility to SLE: Recent progress from GWAS
Yong Cui et al.
JOURNAL OF AUTOIMMUNITY (2013)
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
Matthew S. Macauley et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Copresentation of Antigen and Ligands of Siglec-G Induces B Cell Tolerance Independent of CD22
Fabian Pfrengle et al.
JOURNAL OF IMMUNOLOGY (2013)
Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis
B. Duxbury et al.
LUPUS (2013)
Suppressing the Antibody Response with Siglec Ligands
Lars Nitschke
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling
Jennifer Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Targeting of CD22-positive B-cell lymphoma cells by synthetic divalent sialic acid analogues
Astrid Schweizer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model
Miriam Woehner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
Huan Cao et al.
IMMUNOLOGY (2011)
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo
Bao Hoa Duong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
CD22 x Siglec-G Double-Deficient Mice Have Massively Increased B1 Cell Numbers and Develop Systemic Autoimmunity
Julia Jellusova et al.
JOURNAL OF IMMUNOLOGY (2010)
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity
Ira Surolia et al.
NATURE (2010)
B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase
Annaiah Cariappa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies
Isaac T. W. Harley et al.
NATURE REVIEWS GENETICS (2009)
Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation
Adam H. Courtney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls
A. M. Jacobi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population
Anja Hoffmann et al.
NATURE IMMUNOLOGY (2007)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
High-affinity ligand probes of CD22 overcome the threshold set by cis ligands for binding, endocytosis, and killing of B cells
Brian E. Collins et al.
JOURNAL OF IMMUNOLOGY (2006)
Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling
BE Collins et al.
NATURE IMMUNOLOGY (2006)
Expression of aberrant forms of CD22 on B lymphocytes in Cd22(a) lupus-prone mice affects ligand binding
L Nitschke et al.
INTERNATIONAL IMMUNOLOGY (2006)
Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking
S Han et al.
NATURE CHEMICAL BIOLOGY (2005)
the role of CD22 and other inhibitory co-receptors in B-cell activation
L Nitschke
CURRENT OPINION IN IMMUNOLOGY (2005)
Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact
BE Collins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms
T Angata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity
J Chen et al.
NATURE IMMUNOLOGY (2004)
B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling
J Gerlach et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound
S Kelm et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33
G Whitney et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1
KL Otipoby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor
J Munday et al.
BIOCHEMICAL JOURNAL (2001)
Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice
C Mary et al.
JOURNAL OF IMMUNOLOGY (2000)
Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis
S Bolland et al.
IMMUNITY (2000)